We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Publication, Part of Statistics on NHS Stop Smoking Services in England
Statistics on NHS Stop Smoking Services - England, April 2005 to September 2005, Q2, Quarterly report
Official statistics- Publication Date:
- 13 Feb 2006
- Geographic Coverage:
- England
- Geographical Granularity:
- Regions, Local Authorities
- Date Range:
- 01 Apr 2005 to 30 Sep 2005
Summary
This quarterly report presents provisional results from the monitoring of the NHS Stop Smoking Services (formerly known as the Smoking Cessation Services).
Of those clients who set a quit date during the period April 2005 to September 2005, 137,894 had successfully quit at the 4 week follow up; this compares with 112,250 in the same period in 2004 (an increase of 23%).
Highlights
264,508 people set a quit date through NHS Stop Smoking Services.
At the 4 week follow-up 137,894 had successfully quit (based on self-report), 52% of those setting a quit date.
Of those setting a quit date, success at the four-week follow up increased with age, from 39% of those aged under 18, to 62% of those aged 60 and over.
The majority of those setting a quit date received Nicotine Replacement Therapy (NRT). 82% of people received NRT only, 6% received bupropion only, and 1% received both NRT and bupropion.
The cost of prescription items prescribed in GP practices in England that were dispensed in the community was 20.5 million for NRT, 2.3 million for bupropion (Zyban) a total of 22.7 million
The expenditure on NHS Stop Smoking Services, which does not include the cost of NRT or bupropion on prescription was 22.5 million.
ISBN Reference: 1-84636-037-4
Resources
Last edited: 22 March 2022 1:20 pm